4basebio PLC (AIM:4BB)
London · Delayed Price · Currency is GBP · Price in GBX 500.00
-25.00 (-4.76%)
Jun 16, 2026, 8:05 AM GMT
4basebio Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, 4basebio stock has a consensus rating of "Buy" and an average price target of 1,700p. The average 1-year stock price forecast is 240.00% higher than the current stock price, while the lowest is 1,600p (+220.00%) and the highest is 1,800p (+260.00%).
Price Target: 1,700p (+240.00%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for 4basebio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Sep '25 | Oct '25 | Nov '25 | Feb '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 2 |
Financial Forecast
Revenue This Year
2.60M
from 1.69M
Increased by 53.57%
Revenue Next Year
15.00M
from 2.60M
Increased by 476.92%
EPS This Year
-1.00
from -1.09
EPS Next Year
-0.80
from -1.00
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is GBP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.6M | ||
| Avg | 2.6M | ||
| Low | 2.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 53.6% | ||
| Avg | 53.6% | ||
| Low | 53.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.00 | ||
| Avg | -1.00 | ||
| Low | -1.00 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |